- Microglia-specific Fmr1 deletion causes audiogenic seizures and parvalbumin interneuron loss, reproducing key fragile X syndrome phenotypes.
- FMRP binds lysosomal mRNAs and promotes lysosomal protein expression; its deficiency impairs microglial lysosomal function.
- FMRP loss reduces secreted progranulin, driving PV neuron apoptosis; progranulin overexpression rescues seizures and PV neuron loss, indicating a therapeutic target.
Mol Psychiatry. 2026 Oct 17. doi: 10.1038/s41380-026-03927-3. Online ahead of print.
ABSTRACT
Silencing of the FMRP-encoding FMR1 gene results in fragile X syndrome (FXS), the most common inheritable intellectual disability and autism. FMRP regulates various neuronal functions but clinical trials targeting neurons have failed, suggesting unrecognized disease mechanisms. We find that mice with selective Fmr1 deletion in microglia exhibit audiogenic seizures (AGS) and parvalbumin (PV) neuron loss, recapitulating two key phenotypes observed in FXS (Fmr1-/y) mice. By combining snRNA-Seq and RNA immunoprecipitation, we identify several lysosomal mRNAs as FMRP binding targets. FMRP promotes lysosomal protein expression and its deficiency disrupts lysosomal function in microglia. Notably, FMRP depletion reduces Grn-encoded secretory progranulin and increases PV neuron apoptosis in immature brains. PV neuron density is decreased similarly in Grn+/-, Fmr1-/y, and Grn+/-;Fmr1-/y mice, and progranulin overexpression rescues AGS and PV neuron loss in Fmr1-/y mice. Thus, our study identifies microglia and progranulin as critical regulators of FXS pathogenesis and potential targets for FXS therapy.
PMID:42892634 | DOI:10.1038/s41380-026-03927-3
Share Evidence Blueprint
Save to Google Notes
Search Google Scholar
Save as PDF
⭐ My Revision List
